Daniel DiRenzo

Daniel DiRenzo

Company: Arcus Biosciences

Job title: Associate Director & Project Lead


Dual A2aR/A2bR Antagonism with Etrumadenant Blocks the Immunosuppressive Effects of Adenosine & Enhances Anti-Tumor Immune Responses 9:30 am

Exploring the preclinical characterization of dual A2aR/A2bR antagonist etrumadenant Investigating A2aR selective vs dual A2aR/A2bR antagonism in adenosine-mediated suppression of myeloid cell activityRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.